Front Page Demo Slide

HIPPA & HL7

1
2
3
4
LATEST NEWS:   Facial injuries are common in U.S. nursing home residents - More than 20,000 people living in U.S. nursing homes experienced serious injuries to the face last year, mainly from falling and hitting hard surfaces or while getting in and out of bed, a recent study suggests.
LATEST NEWS:   Foam soap may not measure up to liquid soap - Foam soaps are increasingly replacing traditional liquid soaps in hospitals, nursing homes, schools, the food industry and other public spaces, but the trend may carry a risk, a small study suggests.
LATEST NEWS:   Trump fights for healthcare bill, makes headway with conservatives - WASHINGTON (Reuters) - U.S. President Donald Trump and House of Representatives leaders pushed on Wednesday for votes for their plan to overhaul Obamacare and said they were making progress in their efforts to win over conservative Republicans who have demanded changes to the legislation.
LATEST NEWS:   ‘Healthy’ obese still face higher heart disease risk - Even without high blood pressure or other signs of illness, obese adults have a much higher risk of developing heart disease than normal-weight peers, according to a study from Denmark.
LATEST NEWS:   FDA approves Pfizer, German Merck immunotherapy for skin cancer - (Reuters) - U.S. health regulators on Thursday approved a drug developed by Merck KGaA and Pfizer Inc that helps the immune system to fight a rare form of skin cancer once it has spread to other parts of the body.
LATEST NEWS:   Israel looks to leverage tech in $50 billion medical marijuana market - Tel Aviv (Reuters) - Israel, a leader in marijuana research and health technology, is attracting international investment as it tries to position itself as a cutting-edge exporter in the rapidly-growing market for medical-grade cannabis.
LATEST NEWS:   Uncertain fate of Obamacare causes some hospitals to halt projects, hiring - (Reuters) - Uncertainty surrounding the Republican plan to replace Obamacare is forcing some U.S. hospitals to delay expansion plans, cut costs, or take on added risk to borrow money for capital investment projects, dealing an economic blow to these facilities and the towns they call home.
LATEST NEWS:   Crunch week looms for Sanofi, Roche and GSK at U.S. drugs agency - LONDON (Reuters) - Three of Europe's top drugmakers face critical verdicts from U.S. regulators next week, with Sanofi and Roche likely to win approvals for two new products, while GlaxoSmithKline braces for a potential generic rival.